Power Morcellators are Dangerous and Spread a Rare and Deadly Form of Cancer
Power morcellators are widely used as a minimally-invasive procedure in opposition to a surgical hysterectomy or myomectomy to remove the uterus laparascopically. The power morcellator is a small-bladed instrument that cuts the uterus into small pieces so that those pieces can be extracted. When the power morcellator cuts the uterus, it also cuts the sarcomas, thereby spreading the sarcomas to the abdominal cavity. Because no reliable method exists to distinguish a fibroid tumor from a sarcoma, the FDA has stated that 1 in 350 women have unsuspected and undiagnosed uterine sarcoma. Further, the FDA has estimated that the power morcellator spreads the cancer in up to 65% of the cases.
FDA discourages use of laparoscopic power morcellation for removal of uterus or uterine fibroids… Procedure poses risk of spreading undetected cancerous tissue in women with unsuspected cancer
Based on an analysis of currently available data, the FDA has determined that approximately 1 in 350 women who are undergoing hysterectomy or myomectomy for fibroids have an unsuspected type of uterine cancer called uterine sarcoma. If laparoscopic power morcellation is performed in these women, there is a risk that the procedure will spread the cancerous tissue within the abdomen and pelvis, significantly worsening the patient’s likelihood of long-term survival.
(Laparoscopic Uterine Power Morcellation in Hysterectomy and Myomectomy: FDA Safety Communication, April 17, 2014)
Approximately 25,000 Women Have Been Diagnosed With Leiomyosarcoma Following a Power Morcellator Procedure
There have been medical conferences on the subject of mortality rates and power morcellators. Physicians are speaking out in opposition to their use because no clinical trials were done on the product, and now their patients who are diagnosed with leiomyosarcoma, stage 1, have a 60% life expectancy rate after 5 years; leiomyosarcoma, stage 3 have a 22% life expectancy rate and only a 15% life expectancy rate with a diagnosis of leiomyosarcoma, stage 4. The mortality rate outweighs the benefit of the minimally-invasive procedure.
Johnson & Johnson Has Suspended Sales of Their Power Morcellator
There has been a significant amount of pressure put on morcellator manufacturers, both publicly by cancer victims and through warnings by the FDA to withdraw the power morcellator from the market. Johnson & Johnson, after the public bashing by victims, the stern warning by the FDA and also the filing of hundreds of cancer lawsuits, has withdrawn their power morcellator products from the market.
Call Us Now For a Free and Confidential Consultation
If you or a loved one has been diagnosed with cancer after undergoing a surgery using the power morcellator, please contact us at (855) 480-6881, or use the contact form or chat button on this page for a free and confidential consultation.
Our national team of lawyers has seen tremendous success in representing victims just like you. We have the resources and experience you need to take on the power morcellator manufacturers. We hold the power morcellator companies accountable for their negligence. Don’t let them get away with failing to properly test their product and failing to timely warn you of its deadly side effects. The manufacturers have put big profits in their pockets at your expense. We won’t allow it. We take on big pharma and our results speak for themselves.
Our firm works on a contingency fee basis only, and we will advance all of the case costs up front. This means we only receive a reimbursement for our costs and a fee when the medical device manufacturer pays your claim. If you do not receive a recovery, then you owe us nothing.
Call us NOW at (855) 480-6881 for a free and confidential case evaluation. We’re available 24/7 to answer your questions and address your concerns.